May 4, 2022
Dear International Colleague,
The Food and Drug Administration is co-hosting a regional public meeting with Health Canada on May 11, 2022, to provide information and solicit input ahead of upcoming meetings of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
ICH brings together regulatory authorities and the pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines, with the goal of ensuring that safe, effective and high-quality medicines are developed, registered and maintained in the most resource efficient manner. The overarching governing body of the ICH - the ICH Assembly - and the ICH Management Committee will be holding their biannual meetings on May 21-25, 2022.
US-Canada Regional ICH Consultation
May 11, 2022 | 1:00 - 4:00 p.m. ET
TOPICS COVERED
- ICH Background
- ICH Guidelines Reaching Key Milestones
FDA RESOURCES
INTENDED AUDIENCE
North American regulators, industry, and other stakeholders interested in learning more about current efforts conducted under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) to develop and harmonize scientifically-driven, global standards for safe, effective, and high-quality pharmaceuticals.
|
